Susquehanna International Group, LLP Zynerba Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.33 - $1.39 $73,167 - $308,189	221,719 New	221,719 $281,000
Q2 2022 Aug 15, 2022	SELL	$0.86 - $2.06 $130,529 - $312,664	-151,779 Reduced 93.32%	10,867 $12,000
Q1 2022 May 16, 2022	SELL	$1.83 - $3.02 $384,144 - $633,943	-209,915 Reduced 56.34%	162,646 $333,000
Q4 2021 Feb 14, 2022	BUY	$2.88 - $4.3 $678,804 - $1.01 Million	235,696 Added 172.21%	372,561 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$3.72 - $5.35 $346,648 - $498,539	93,185 Added 213.34%	136,865 $580,000
Q1 2021 May 17, 2021	SELL	$3.33 - $8.76 $312,836 - $822,958	-93,945 Reduced 68.26%	43,680 $203,000
Q4 2020 Feb 16, 2021	BUY	$3.27 - $4.64 $114,675 - $162,720	35,069 Added 34.19%	137,625 $454,000
Q3 2020 Nov 16, 2020	BUY	$3.23 - $4.3 $154,507 - $205,690	47,835 Added 87.42%	102,556 $339,000
Q2 2020 Aug 14, 2020	SELL	$3.31 - $6.54 $718,134 - $1.42 Million	-216,959 Reduced 79.86%	54,721 $184,000
Q1 2020 May 15, 2020	BUY	$2.9 - $6.16 $76,522 - $162,543	26,387 Added 10.76%	271,680 $1.04 Million
Q4 2019 Feb 14, 2020	BUY	$5.61 - $8.57 $1.05 Million - $1.61 Million	187,876 Added 327.21%	245,293 $1.48 Million
Q3 2019 Nov 14, 2019	BUY	$7.56 - $15.44 $349,158 - $713,096	46,185 Added 411.19%	57,417 $434,000
Q2 2019 Aug 16, 2019	SELL	$5.4 - $15.5 $472,311 - $1.36 Million	-87,465 Reduced 88.62%	11,232 $152,000
Q1 2019 May 15, 2019	SELL	$3.6 - $6.22 $403,189 - $696,621	-111,997 Reduced 53.16%	98,697 $535,000
Q4 2018 Feb 14, 2019	SELL	$2.89 - $7.91 $342,661 - $937,872	-118,568 Reduced 36.01%	210,694 $625,000
Q3 2018 Nov 14, 2018	BUY	$5.59 - $10.45 $1.17 Million - $2.18 Million	208,871 Added 173.49%	329,262 $2.69 Million
Q2 2018 Aug 14, 2018	SELL	$7.98 - $12.39 $400,133 - $621,259	-50,142 Reduced 29.4%	120,391 $1.17 Million
Q4 2017 Feb 14, 2018	BUY	$8.69 - $14.59 $1.48 Million - $2.49 Million	170,533	170,533 $2.14 Million

Others Institutions Holding ZYNE

# of Institutions

Shares Held

774K

Call Options Held

Put Options Held

View Full List

About Zynerba Pharmaceuticals, Inc.

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

More about ZYNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account